Langerhans cell histiocytosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 39: | Line 39: | ||
==Treatment== | ==Treatment== | ||
[[Langerhans cell histiocytosis medical therapy|Medical Therapy]] | [[Langerhans cell histiocytosis surgery|Surgery]] | [[Langerhans cell histiocytosis primary prevention|Primary Prevention]] | [[Langerhans cell histiocytosis secondary prevention|Secondary Prevention]] | [[Langerhans cell histiocytosis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Langerhans cell histiocytosis future or investigational therapies|Future or Investigational Therapies]] | [[Langerhans cell histiocytosis medical therapy|Medical Therapy]] | [[Langerhans cell histiocytosis surgery|Surgery]] | [[Langerhans cell histiocytosis primary prevention|Primary Prevention]] | [[Langerhans cell histiocytosis secondary prevention|Secondary Prevention]] | [[Langerhans cell histiocytosis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Langerhans cell histiocytosis future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | |||
[[Langerhans cell histiocytosis case study one|Case #1]] | |||
==Related chapters== | ==Related chapters== |
Revision as of 20:32, 13 September 2012
For patient information, click here Template:DiseaseDisorder infobox
Langerhans cell histiocytosis Microchapters |
Differentiating Langerhans cell histiocytosis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Langerhans cell histiocytosis On the Web |
American Roentgen Ray Society Images of Langerhans cell histiocytosis |
Directions to Hospitals Treating Langerhans cell histiocytosis |
Risk calculators and risk factors for Langerhans cell histiocytosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Synonyms and keywords: Histiocytosis X; histiocytosis X syndrome; Hand-Schüller-Christian disease; Letterer-Siwe disease; histiocytosis X; eosinophilic granulomatosis unspecified; Langerhans cell granulomatosis; Langerhans cell histiocytosis-Hashimoto-Pritzker type; Langerhans cell histiocytosis, disseminated (clinical); Langerhans cell histiocytosis, unifocal (clinical); Langerhans cell histiocytosis of the lung; non-lipid reticuloendotheliosis; eosinophilic granuoloma; pulmonary histiocytosis X; pulmonary Langerhans cell granulomatosis
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Langerhans cell histiocytosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History amd Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies